Reaction
Herpes Simplex Reactivation reporting signals
As of the last recalculation, Herpes Simplex Reactivation appears in 370 FAERS reports alongside 16 co-occurring drug terms. The strongest observed disproportionality signal is THIOTEPA (PRR 124.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Thiotepa | 20 | 124.5 | 124.7 |
| Posaconazole Delayed-Release | 15 | 80.0 | 80.1 |
| Remdesivir | 15 | 66.0 | 66.0 |
| Posaconazole | 17 | 61.6 | 61.7 |
| Baricitinib | 8 | 47.7 | 47.7 |
| Sirolimus | 11 | 47.3 | 47.3 |
| Bupivacaine | 7 | 42.9 | 43.0 |
| Anti-Thymocyte Globulin (Rabbit) | 6 | 42.5 | 42.5 |
| Busulfan | 11 | 40.5 | 40.5 |
| Ganciclovir | 7 | 39.2 | 39.2 |
| Ganciclovir Sodium | 7 | 37.9 | 37.9 |
| Fludarabine Phosphate | 24 | 36.6 | 36.7 |
| Aprepitant | 11 | 34.5 | 34.5 |
| Bleomycin Sulfate | 6 | 33.2 | 33.2 |
| Belimumab | 16 | 29.7 | 29.7 |
| Romiplostim | 6 | 22.8 | 22.8 |